Leading orthodontic consultancy and SEO firm identifies practices in the DFW metroplex, highlighting doctor-led models ...

Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final data from three clinical trials of CardiAMP cell therapy, with the latest Phase III results presented ...

ABS-201 Phase I/IIa progress, early safety/PK, AGA & endometriosis timelines, cash runway & catalysts—read now.

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at ...

AEMD READ THE FULL AEMD RESEARCH REPORT DSMB recommends AEMD progress clinical trial to the final third cohort Aethlon Medical (NASDAQ: AEMD) announced today that the independent Data Safety ...

At AD/PD 2026, Roche announced that patients treated with prasinezumab for five years demonstrated a sustained slowing of ...

To learn more about JDIX and its newly launched platforms, visit: Additional details regarding the announcement are ...

All six participants tolerated surgical and intra-cochlear SENS-501 administration well, with no serious adverse events ...

Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...